Use of Dynamic Arm Supports to Promote Activities of Daily Living in Individuals With DMD
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03531788 |
Recruitment Status :
Completed
First Posted : May 22, 2018
Last Update Posted : February 2, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Duchenne Muscular Dystrophy | Device: Armon Ayura (Kinova) Device: JAECO Wrex | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 19 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | Participants will be randomly assigned to trial a dynamic arm support (Armon Ayura (Kinova) or JAECO WREX) |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Use of Dynamic Arm Support Devices for Upper Limb Function in Non-Ambulatory Men With Duchenne Muscular Dystrophy (DMD) |
Actual Study Start Date : | August 30, 2018 |
Actual Primary Completion Date : | December 31, 2020 |
Actual Study Completion Date : | December 31, 2020 |

Arm | Intervention/treatment |
---|---|
Experimental: Armon Ayura (Kinova)
Participants will trial the Armon Ayura dynamic arm support.
|
Device: Armon Ayura (Kinova)
Actively assisted mechanical arm support (electric powered to balance arm)
Other Name: Kinova |
Experimental: JAECO WREX
Participants will trial the JAECO Wilmington Robotic EXoskeleton (WREX) dynamic arm support.
|
Device: JAECO Wrex
Passive mechanical arm support (elastic bands to balance arm) |
- Change in Upper Extremity Acceleration through Actigraphy [ Time Frame: Activity monitoring occurs throughout the trial period from baseline to 8 weeks ]Measured through the ActiGraph GT9X wrist worn activity monitoring device - The multi-axis accelerometer measures acceleration normalized to Earth gravity (g) in the x, y, and z axis.
- Change in Upper Extremity Position through Actigraphy [ Time Frame: Activity monitoring occurs throughout the trial period from baseline to 8 weeks ]Measured through the ActiGraph GT9X wrist worn activity monitoring device - The multi-axis gyroscope measures angular rates in degrees per second in the x, y, and z axis.
- Goal Attainment Scale (GAS) [ Time Frame: The GAS will be completed and scored at baseline, then scored again at 6 weeks ]The GAS is a personal interview which allows the individual to determine important and personally meaningful goals. Goal scaling is standardized in order to calculate the extent to which a patient's goals are met.The GAS uses a 5-point rating scale to determine if the goal was not met (-2) up to a greater than expected meeting of the personal goal (+2). A score of 0 indicates the goal was met as anticipated.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 14 Years and older (Child, Adult, Older Adult) |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- 14 years of age or older
- Self-report diagnosis of Duchenne muscular dystrophy (DMD)
- Use a wheelchair for mobility
- Score 3-5 on the Brooke UE Scale
- Self-report of needs assistance/unable to achieve independently on at least 10 items on the UL ADL self-report questionnaire
- Able to follow instructions
- Informed consent provided by self (18 and over) or by parent or legal guardian (if under the age of 18)
Exclusion Criteria:
- Does not have minimum level of UE function to operate the assigned dynamic arm support (Score of 6 on the Brooke UE scale or any other impairment limiting use)
- The assigned dynamic arm support is unable to be mounted to wheelchair (mounts will vary based on manufacturer/model of wheelchair)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03531788
United States, Pennsylvania | |
University of Pittsburgh | |
Pittsburgh, Pennsylvania, United States, 15260 |
Principal Investigator: | Roxanna M Bendixen, PhD | University of Pittsburgh |
Responsible Party: | Roxanna Marie Bendixen, Associate Professor, University of Pittsburgh |
ClinicalTrials.gov Identifier: | NCT03531788 |
Other Study ID Numbers: |
18010005 |
First Posted: | May 22, 2018 Key Record Dates |
Last Update Posted: | February 2, 2021 |
Last Verified: | February 2021 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | Yes |
Product Manufactured in and Exported from the U.S.: | No |
dynamic arm support mobile arm support rehabilitation occupational therapy |
Muscular Dystrophies Muscular Dystrophy, Duchenne Muscular Disorders, Atrophic Muscular Diseases Musculoskeletal Diseases |
Neuromuscular Diseases Nervous System Diseases Genetic Diseases, Inborn Genetic Diseases, X-Linked |